{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:45:12Z","timestamp":1790423112530,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.msard.2023.104511","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T02:12:14Z","timestamp":1673057534000},"page":"104511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The epidemiology and burden of neuromyelitis optica spectrum disorder, multiple sclerosis, and MOG antibody-associated disease in a province in Thailand: A population-based study"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4021-6450","authenticated-orcid":false,"given":"Nanthaya","family":"Tisavipat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pornpong","family":"Jitpratoom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasitorn","family":"Siritho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naraporn","family":"Prayoonwiwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metha","family":"Apiwattanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adhiratha","family":"Boonyasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natthapon","family":"Rattanathamsakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3342-2755","authenticated-orcid":false,"given":"Jiraporn","family":"Jitprapaikulsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.msard.2023.104511_bib0048","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001071","article-title":"Modern Look at Transverse Myelitis and Inflammatory Myelopathy: Epidemiology of the National Veterans Health Administration Population","volume":"8","author":"Abbatemarco","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.msard.2023.104511_bib0006","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/1352458519887328","article-title":"Race and ethnicity on MS presentation and disease course","volume":"26","author":"Amezcua","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.104511_bib0021","series-title":"WHO Methods and Data Sources For Global Burden of Disease Estimates 2000-2019","year":"2020"},{"key":"10.1016\/j.msard.2023.104511_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103414","article-title":"Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: case report and systematic review","volume":"58","author":"Anamnart","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.msard.2023.104511_bib0065","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/jech.54.3.200","article-title":"Disability and health status: ethnic differences among women in the United States","volume":"54","author":"Andresen","year":"2000","journal-title":"J. Epidemiol. Community Health"},{"issue":"6","key":"10.1016\/j.msard.2023.104511_bib0007","doi-asserted-by":"crossref","first-page":"e1060","DOI":"10.1212\/NXI.0000000000001060","article-title":"Clinical features of COVID-19 on patients with neuromyelitis optica spectrum disorders","volume":"8","author":"Apostolos-Pereira","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.msard.2023.104511_bib0044","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1212\/01.wnl.0000339482.84392.bd","article-title":"Incidence of acquired demyelination of the CNS in Canadian children","volume":"72","author":"Banwell","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104511_bib0009","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10654-015-0034-5","article-title":"Development of the standards of reporting of neurological disorders (STROND) checklist: a guideline for the reporting of incidence and prevalence studies in neuroepidemiology","volume":"30","author":"Bennett","year":"2015","journal-title":"Eur. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.msard.2023.104511_bib0043","doi-asserted-by":"crossref","first-page":"A395","DOI":"10.1016\/j.autrev.2009.12.007","article-title":"The epidemiology of transverse myelitis","volume":"9","author":"Bhat","year":"2010","journal-title":"Autoimmun. Rev."},{"issue":"8","key":"10.1016\/j.msard.2023.104511_bib0046","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1177\/1352458517713669","article-title":"Pediatric-onset multiple sclerosis and other acquired demyelinating syndromes of the central nervous system in Denmark during 1977\u20132015: a nationwide population-based incidence study","volume":"24","author":"Boesen","year":"2018","journal-title":"Mult. Scler. J."},{"issue":"12","key":"10.1016\/j.msard.2023.104511_bib0041","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/jamaneurol.2020.3502","article-title":"Trends in optic neuritis incidence and prevalence in the UK and association with systemic and neurologic disease","volume":"77","author":"Braithwaite","year":"2020","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.msard.2023.104511_bib0023","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","article-title":"Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.msard.2023.104511_bib0037","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/1352458519845112","article-title":"The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults","volume":"26","author":"de Mol","year":"2020","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2023.104511_bib0056","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/jnnp-2021-327200","article-title":"mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis","volume":"93","author":"Di Filippo","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2023.104511_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103424","article-title":"Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD","volume":"58","author":"Dinoto","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2023.104511_bib0054","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12883-022-02590-9","article-title":"Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study","volume":"22","author":"Etemadifar","year":"2022","journal-title":"BMC Neurol."},{"issue":"5","key":"10.1016\/j.msard.2023.104511_bib0060","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Feigin","year":"2019","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.msard.2023.104511_bib0004","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2023.104511_bib0035","first-page":"160","article-title":"The epidemiology of myelin oligodendrocyte glycoprotein antibody associated disorders","author":"Flanagan","year":"2019","journal-title":"Mult. Scler. Journal"},{"issue":"3","key":"10.1016\/j.msard.2023.104511_bib0051","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1474-4422(22)00043-6","article-title":"MOG antibody-associated disease after vaccination with ChAdOx1 nCoV-19","volume":"21","author":"Francis","year":"2022","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.msard.2023.104511_bib0018","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/WNL.59.4.499","article-title":"Proposed diagnostic criteria and nosology of acute transverse myelitis","volume":"59","year":"2002","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2023.104511_bib0064","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12963-014-0020-2","article-title":"Review of disability weight studies: comparison of methodological choices and values","volume":"12","author":"Haagsma","year":"2014","journal-title":"Popul. Health Metr."},{"key":"10.1016\/j.msard.2023.104511_bib0039","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajo.2020.07.014","article-title":"Population-based incidence of optic neuritis in the era of aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies","volume":"220","author":"Hassan","year":"2020","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.msard.2023.104511_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00501","article-title":"Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide","volume":"11","author":"Hor","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2023.104511_bib0028","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.msard.2017.10.015","article-title":"Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island, Malaysia, and a review of worldwide prevalence","volume":"19","author":"Hor Jyh","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"11","key":"10.1016\/j.msard.2023.104511_bib0061","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055392","article-title":"Predictors of relapse in MOG antibody associated disease: a cohort study","volume":"11","author":"Huda","year":"2021","journal-title":"BMJ Open"},{"issue":"1\u20132","key":"10.1016\/j.msard.2023.104511_bib0014","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2010.01.002","article-title":"Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen","volume":"291","author":"Jarius","year":"2010","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2023.104511_bib0012","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J Neuroinflammation"},{"issue":"22","key":"10.1016\/j.msard.2023.104511_bib0002","doi-asserted-by":"crossref","first-page":"e2089","DOI":"10.1212\/WNL.0000000000006574","article-title":"Racial differences in neuromyelitis optica spectrum disorder","volume":"91","author":"Kim","year":"2018","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.msard.2023.104511_bib0017","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/1352458513484547","article-title":"International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions","volume":"19","author":"Krupp","year":"2013","journal-title":"Mult. Scler. J."},{"issue":"11","key":"10.1016\/j.msard.2023.104511_bib0024","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.msard.2023.104511_bib0063","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","article-title":"Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG\u2013associated disorders","volume":"75","author":"L\u00f3pez-Chiriboga","year":"2018","journal-title":"JAMA Neurol."},{"issue":"12","key":"10.1016\/j.msard.2023.104511_bib0008","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1001\/jamaneurol.2014.2633","article-title":"Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases","volume":"71","author":"Langer-Gould","year":"2014","journal-title":"JAMA Neurol."},{"issue":"17","key":"10.1016\/j.msard.2023.104511_bib0027","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.3346\/jkms.2020.35.e115","article-title":"Prevalence and incidence of neuromyelitis optica spectrum disorder in Korea: population based study","volume":"35","author":"Lee","year":"2020","journal-title":"J. Korean Med. Sci."},{"issue":"3","key":"10.1016\/j.msard.2023.104511_bib0040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ophtha.2019.09.032","article-title":"Population-based Incidence of pediatric and adult optic neuritis and the risk of multiple sclerosis","volume":"127","author":"Lee","year":"2020","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.msard.2023.104511_bib0052","first-page":"95","article-title":"HLA, molecular mimicry and multiple sclerosis","volume":"2","author":"Liblau","year":"2000","journal-title":"Rev. Immunogenet."},{"key":"10.1016\/j.msard.2023.104511_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103253","article-title":"High titers of myelin oligodendrocyte glycoprotein antibody are only observed close to clinical events in pediatrics","volume":"56","author":"Lui","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.msard.2023.104511_bib0053","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/ene.15304","article-title":"Is there a correlation between MOG-associated disorder and SARS-CoV-2 infection?","volume":"29","author":"Mariotto","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.msard.2023.104511_bib0057","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.msard.2018.05.003","article-title":"Vaccines and the association with relapses in patients with neuromyelitis optica spectrum disorder","volume":"23","author":"Mealy","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.msard.2023.104511_bib0026","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/jnnp-2017-317321","article-title":"Nationwide epidemiological study of neuromyelitis optica in Japan","volume":"89","author":"Miyamoto","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2023.104511_bib0025","series-title":"Global Burden of Disease Study 2019 (GBD 2019) Reference Life Table","year":"2021"},{"key":"10.1016\/j.msard.2023.104511_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.765954","article-title":"Case report: multiple sclerosis relapses after vaccination against SARS-CoV2: a series of clinical cases","volume":"12","author":"Nistri","year":"2021","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2023.104511_bib0030","first-page":"59","article-title":"Worldwide incidence and prevalence of neuromyelitis optica","volume":"96","author":"Papp","year":"2021","journal-title":"Syst. Rev."},{"key":"10.1016\/j.msard.2023.104511_bib0020","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1474-4422(22)00200-9","article-title":"Diagnosis and classification of optic neuritis","volume":"21","author":"Petzold","year":"2022","journal-title":"Lancet Neurol."},{"issue":"9 Suppl 2","key":"10.1016\/j.msard.2023.104511_bib0019","first-page":"S38","article-title":"Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome","volume":"87","author":"Pohl","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104511_bib0032","unstructured":"Prayoonwiwat N, Apiwattanakul M, Pasogpakdee P, et\u00a0al. Prevalence of idiopathic inflammatory demyelinating central nervous system disorders in Thailand. Taipei, Taiwan: PACTRIM; 2014."},{"issue":"7","key":"10.1016\/j.msard.2023.104511_bib0003","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1093\/brain\/awab104","article-title":"The latitude gradient for multiple sclerosis prevalence is established in the early life course","volume":"144","author":"Sabel","year":"2021","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.msard.2023.104511_bib0022","doi-asserted-by":"crossref","first-page":"e712","DOI":"10.1016\/S2214-109X(15)00069-8","article-title":"Disability weights for the Global Burden of Disease 2013 study","volume":"3","author":"Salomon","year":"2015","journal-title":"Lancet Glob. Health"},{"issue":"1","key":"10.1016\/j.msard.2023.104511_bib0038","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.42780","article-title":"Factors associated with relapse and treatment of myelin oligodendrocyte glycoprotein antibody\u2013associated disease in the United Kingdom","volume":"5","author":"Satukijchai","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.msard.2023.104511_bib0047","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1212\/WNL.0000000000007828","article-title":"Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology","volume":"93","author":"Sechi","year":"2019","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2023.104511_bib0016","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/jamaneurol.2021.0912","article-title":"Positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing","volume":"78","author":"Sechi","year":"2021","journal-title":"JAMA Neurol."},{"issue":"12","key":"10.1016\/j.msard.2023.104511_bib0036","first-page":"1381","article-title":"Seroprevalence and clinical phenotype of MOG-IgG-associated disorders in Sri Lanka","volume":"90","author":"Senanayake","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"11","key":"10.1016\/j.msard.2023.104511_bib0031","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/jnnp-2018-320189","article-title":"Latitude continues to be significantly associated with the prevalence of multiple sclerosis: an updated meta-analysis","volume":"90","author":"Simpson","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"10.1016\/j.msard.2023.104511_bib0034","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/jnnp-2022-328932","article-title":"Increasing incidence and prevalence of multiple sclerosis in the Greater Hobart cohort of Tasmania, Australia","volume":"93","author":"Simpson-Yap","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.msard.2023.104511_bib0013","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1212\/WNL.0b013e31822c61b1","article-title":"AQP4 antibody-positive Thai cases: clinical features and diagnostic problems","volume":"77","author":"Siritho","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104511_bib0059","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.msard.2018.07.004","article-title":"Health utilities of patients with multiple sclerosis and neuromyelitis optica spectrum disorders in Thailand","volume":"24","author":"Siritho","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104511_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103080","article-title":"Asian and African\/Caribbean AQP4-NMOSD patient outcomes according to self-identified race and place of residence","volume":"53","author":"Soares-dos-Reis","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2023.104511_bib0042","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jamaophthalmol.2017.5470","article-title":"Incidence and causes of overdiagnosis of optic neuritis","volume":"136","author":"Stunkel","year":"2018","journal-title":"JAMA Ophthalmol."},{"issue":"2","key":"10.1016\/j.msard.2023.104511_bib0010","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2023.104511_bib0029","article-title":"Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: a national population-based study","volume":"2","author":"Tian","year":"2020","journal-title":"Lancet Reg. Health West. Pac."},{"key":"10.1016\/j.msard.2023.104511_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103907","article-title":"A quarter-century report on neuromyelitis optica spectrum disorder in Thailand: a single-center tertiary care cohort","volume":"63","author":"Tisavipat","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"14","key":"10.1016\/j.msard.2023.104511_bib0033","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"issue":"11","key":"10.1016\/j.msard.2023.104511_bib0015","doi-asserted-by":"crossref","first-page":"e1250","DOI":"10.1212\/WNL.0000000000007096","article-title":"A multicenter comparison of MOG-IgG cell-based assays","volume":"92","author":"Waters","year":"2019","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2023.104511_bib0011","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2023.104511_bib0045","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s12264-021-00642-7","article-title":"Incidence and mortality of acute disseminated encephalomyelitis in china: a nationwide population-based study","volume":"37","author":"Xiu","year":"2021","journal-title":"Neurosci. Bull."}],"updated-by":[{"DOI":"10.1016\/j.msard.2026.107240","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000}},{"DOI":"10.1016\/j.msard.2026.107240","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823000159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823000159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:57:55Z","timestamp":1785880675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823000159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":65,"alternative-id":["S2211034823000159"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.104511","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The epidemiology and burden of neuromyelitis optica spectrum disorder, multiple sclerosis, and MOG antibody-associated disease in a province in Thailand: A population-based study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.104511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104511"}}